Nom du produit:2-Fluoro-4-nitrotoluene
IUPAC Name:2-fluoro-1-methyl-4-nitrobenzene
- CAS:1427-07-2
- Formule moléculaire:C7H6FNO2
- Pureté:95%
- Numéro de catalogue:CM244361
- Poids moléculaire:155.13
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1427-07-2
- Formule moléculaire:C7H6FNO2
- Point de fusion:-
- Code SMILES:CC1=CC=C([N+]([O-])=O)C=C1F
- Densité:
- Numéro de catalogue:CM244361
- Poids moléculaire:155.13
- Point d'ébullition:
- N° Mdl:
- Stockage:
Column Infos
- Enzalutamide
- Aug. 23, 2023, FDA grants priority review for XTANDI(enzalutamide) in non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence.
XTANDI (enzalutamide) is an androgen receptor signaling inhibitor. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.XTANDI is currently approved for one or more of these indications in more than 100 countries, including in the U.S., European Union and Japan. Over one million patients have been treated with XTANDI globally.